跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,048 条关于
“Asteroid 633 Therapeutics”
全部
19,048
临床试验
5,541
药物
3,485
机构
1,125
资讯
8,897
上个月
Shared Lysosomal Pathway Drives Neurodegeneration in Rare Childhood Dementia and Alzheimer's, UC San Diego Study Reveals
去年
Ultragenyx's Setrusumab Receives FDA Breakthrough Therapy Designation for Osteogenesis Imperfecta
去年
Ultragenyx and Mereo BioPharma Advance Setrusumab Phase 3 Studies for Osteogenesis Imperfecta Toward Year-End Analysis
去年
Setrusumab Receives FDA Breakthrough Therapy Designation for Osteogenesis Imperfecta
去年
Biogen Launches Phase 3 Pediatric Trial of Omaveloxolone for Friedreich Ataxia
2年前
Setrusumab Shows Sustained Fracture Reduction in Osteogenesis Imperfecta Patients
去年
Remimazolam Demonstrates Superior Safety Profile Over Propofol in ICU Bronchoscopy Procedures
去年
AbCellera Advances Two First-in-Class Antibody Therapies to Phase 1 Trials Following Strategic Pivot
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
3个月前
XRHealth Acquires Swing Therapeutics to Expand Digital Therapeutics Portfolio
第 1 页,共 890 页
上一页
下一页